News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,906 Results
Type
Article (159)
Company Profile (1)
Press Release (1746)
Section
Business (702)
Career Advice (1)
Deals (108)
Drug Development (322)
Employer Resources (4)
FDA (64)
Job Trends (40)
News (1199)
Policy (109)
Tag
Academia (2)
Adcomms (1)
Alliances (162)
Alzheimer's disease (1)
Antibody-drug conjugate (ADC) (10)
Approvals (68)
Artificial intelligence (3)
Bankruptcy (1)
Best Places to Work (23)
Biotechnology (1)
Brain cancer (1)
Cancer (20)
Career advice (1)
Clinical research (316)
Collaboration (8)
C-suite (8)
Data (28)
Diagnostics (5)
Diversity, equity & inclusion (1)
Drug discovery (1)
Earnings (276)
Employer branding (1)
Employer resources (3)
Events (199)
Executive appointments (10)
FDA (77)
Fibrodysplasia Ossificans Progressiva (1)
Funding (2)
GLP-1 (3)
Government (8)
Guidances (6)
Healthcare (25)
Immunology and inflammation (1)
Indications (1)
Infectious disease (1)
IPO (47)
Job creations (18)
Job search strategy (1)
Kidney cancer (1)
Layoffs (7)
Legal (6)
Lymphoma (1)
Management (1)
MASH (2)
Medical device (1)
Medtech (1)
Mergers & acquisitions (67)
Metabolic disorders (3)
Neurodegenerative disease (1)
Neuroscience (4)
NextGen: Class of 2026 (9)
Non-profit (7)
Obesity (1)
Opinion (1)
Pancreatic cancer (3)
People (287)
Phase 1 (58)
Phase 2 (99)
Phase 3 (182)
Pipeline (29)
Postmarket research (3)
Preclinical (12)
Prostate cancer (2)
Psychedelics (1)
Rare diseases (6)
Real estate (14)
Recruiting (1)
Regulatory (110)
Research institute (2)
RSV (1)
Series A (2)
Startups (15)
The Weekly (1)
Date
Last 7 days (2)
Last 30 days (6)
Last 365 days (110)
2026 (10)
2025 (109)
2024 (115)
2023 (146)
2022 (198)
2021 (164)
2020 (146)
2019 (126)
2018 (103)
2017 (107)
2016 (79)
2015 (79)
2014 (74)
2013 (50)
2012 (62)
2011 (65)
2010 (69)
Location
Africa (2)
Asia (58)
Australia (3)
California (32)
Canada (8)
China (4)
Europe (943)
Florida (1)
Illinois (4)
Japan (1)
Maryland (2)
Massachusetts (41)
New Jersey (2)
New York (4)
Northern California (23)
South America (3)
Southern California (3)
Texas (1)
United States (89)
Wisconsin (1)
1,906 Results for "ipsen".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS
January 14, 2026
·
10 min read
Press Releases
Ipsen nominates Peter Guenter to its Board of Directors
January 29, 2026
·
6 min read
Press Releases
Origami Therapeutics Announces Global Collaboration with Ipsen to Advance Protein Degrader Program
February 2, 2026
·
2 min read
Press Releases
U.S. FDA grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in first line unfit Acute Myeloid Leukemia
January 14, 2026
·
8 min read
Press Releases
Ipsen – Half year statement – 2025 12 31
January 7, 2026
·
5 min read
Press Releases
Ipsen provides update on legacy of Henri Beaufour
December 5, 2025
·
5 min read
Press Releases
Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline
December 16, 2025
·
4 min read
Press Releases
Ipsen mourns the passing of Henri Beaufour, a founding family Board member
December 1, 2025
·
6 min read
Press Releases
Ipsen expands early development pipeline with Simcere Zaiming’s innovative antibody drug conjugate
December 22, 2025
·
7 min read
Press Releases
Ipsen update on Phase II FALKON trial in patients with ultra-rare bone disease, fibrodysplasia ossificans progressiva (FOP)
December 19, 2025
·
7 min read
1 of 191
Next
